Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.

Saved in:
Bibliographic Details
Title: Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.
Authors: Gaete-Argel A; Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile., Saavedra-Alarcón V; Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile., Sauré D; Departamento de Ingenieria Industrial, Facultad de Ciencias Físicas y Matemáticas, University of Chile and Institutos Sistemas Complejos de Ingenieria, Santiago, Chile., Alonso-Palomares L; Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile., Acevedo ML; Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile., Alarcón M; Clínica Santa María, Santiago, Chile., Bueno SM; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile., Kalergis AM; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.; Departamento de Endocrinología, Facultad de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile., Soto-Rifo R; Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile., Valiente-Echeverría F; Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile., Cortes CP; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Clínica Santa María, Santiago, Chile.; Departamento de Medicina Interna Centro, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Source: Frontiers in immunology [Front Immunol] 2023 Mar 13; Vol. 14, pp. 1135478. Date of Electronic Publication: 2023 Mar 13 (Print Publication: 2023).
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36999018
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gaete-Argel+A%22">Gaete-Argel A</searchLink>; Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Saavedra-Alarcón+V%22">Saavedra-Alarcón V</searchLink>; Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Sauré+D%22">Sauré D</searchLink>; Departamento de Ingenieria Industrial, Facultad de Ciencias Físicas y Matemáticas, University of Chile and Institutos Sistemas Complejos de Ingenieria, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Alonso-Palomares+L%22">Alonso-Palomares L</searchLink>; Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Acevedo+ML%22">Acevedo ML</searchLink>; Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Alarcón+M%22">Alarcón M</searchLink>; Clínica Santa María, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Bueno+SM%22">Bueno SM</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Kalergis+AM%22">Kalergis AM</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.; Departamento de Endocrinología, Facultad de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Soto-Rifo+R%22">Soto-Rifo R</searchLink>; Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Valiente-Echeverría+F%22">Valiente-Echeverría F</searchLink>; Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Cortes+CP%22">Cortes CP</searchLink>; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Clínica Santa María, Santiago, Chile.; Departamento de Medicina Interna Centro, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Mar 13; Vol. 14, pp. 1135478. <i>Date of Electronic Publication: </i>2023 Mar 13 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36999018
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2023.1135478
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1135478
    Titles:
      – TitleFull: Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gaete-Argel A
      – PersonEntity:
          Name:
            NameFull: Saavedra-Alarcón V
      – PersonEntity:
          Name:
            NameFull: Sauré D
      – PersonEntity:
          Name:
            NameFull: Alonso-Palomares L
      – PersonEntity:
          Name:
            NameFull: Acevedo ML
      – PersonEntity:
          Name:
            NameFull: Alarcón M
      – PersonEntity:
          Name:
            NameFull: Bueno SM
      – PersonEntity:
          Name:
            NameFull: Kalergis AM
      – PersonEntity:
          Name:
            NameFull: Soto-Rifo R
      – PersonEntity:
          Name:
            NameFull: Valiente-Echeverría F
      – PersonEntity:
          Name:
            NameFull: Cortes CP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 03
              Text: 2023 Mar 13
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1